Abstract
Increased protein glycation has been mechanistically linked to accelerated vascular pathobiology in diabetes. To test the influence of protein modified by Amadori glucose adducts on vascular cell biology, we examined the effect of glycated albumin on replicative capacity and basement membrane collagen production by aortic endothelial cells in culture. Relative to carbohydrate-free albumin, which supported cell proliferation and Type IV collagen synthesis, glycated albumin significantly inhibited3H-thymidine incorporation and Type IV collagen production. The glycated albumin-induced effects were prevented by monoclonal antibodies (A717) that specifically react with Amadori-modified albumin, but not by IgG that was unreactive with glycated albumin. A717 had no effect on thymidine incorporation or collagen synthesis by cells cultured in the presence of nonglycated albumin. The findings indicate that the interaction of glycated albumin with endothelial cells, which have been shown to display dose-responsive, saturable receptors, limits cell replication and triggers maladaptive biosynthetic programs, which may contribute to degenerative macrovascular disease in diabetes.
Similar content being viewed by others
References
Luscher TF, Tanner FC, Tschudi MR, Noll G: Endothelial dysfunction in coronary artery disease. Annu Rev Med 44: 395–418, 1993
Nilsson J: Growth factors and the pathogenesis of atherosclerosis. Atherosclerosis 62: 185–199, 1986
Ross R: The pathogenesis of atherosclerosis: an update. New Engl J Med 314: 488–500, 1986
Cagliero E, Maiello M, Boeri D, Roy S, Lorenzi M: Increased expression of basement membrane components in human endothelial cells cultured in high glucose. J Clin Invest 83: 735–738 1988
Danne T, Spiro MJ, Spiro R: Effect of high glucose on Type IV collagen production by cultured glomerular epithelial, endothelial and mesangial cells. Diabetes 42: 170–177, 1992
Lorenzi M, Cagliero E, Toledo S: Glucose toxicity for human endothelial cells in culture: Delayed replication, disturbed cell cycle and accelerated death. Diabetes 34: 621–627, 1985
Lorenzi M, Nordberg JA, Toledo S: High glucose prolongs cells cycle traversal of cultured human endothelial cells. Diabetes 36: 1261–1267, 1987
Cohen MP: Ziyadeh FN: Amadori glucose adducts modulate mesangial cell growth and collagen gene expression. Kidney Int 45: 475–484, 1994
Wu YV, Cohen MP: Identification of aortic endothelial cell binding proteins for Amadori adducts in glycated albumin. Biochem Biophys Res Comm 193: 1131–1136, 1993
Wu VY, Cohen MP: Receptors specific for Amadori-modified glycated albumin on murine endothelial cells. Biochem Biophys Res Comm 198: 734–739, 1994
Cohen MP: Diabetes and Protein Glycosylation: Measurement and Biologic Relevance. Springer Verlag, New York, 1986
Cohen MP, Hud E: Measurement of plasma glycoalbumin levels with a monoclonal antibody based ELISA. J Immunolog Meth 122: 279–283, 1989
Cohen MP, Hud E: Production and characterization of monoclonal antibodies against human glycoalbumin. J Immunolog Meth 117: 121–129, 1989
Ney KA, Colley KJ, Pizzo SC: The standardization of the thiobarbituric acid assay for nonenzymatic glucosylation of human serum albumin. Anal Biochem 118: 294–300, 1981
Sell DR, Nagaraj RH, Grandee SK, Odetta P, Lapolla A, Fogarty J, Monnier V: Pentosidine: a molecular marker for the cumulative damage to proteins in diabetes, aging, and uremia. Diabetes/Metabolism Reviews 7: 239–251, 1991
Smith PR, Thornalley PJ: Mechanism of the degradation of nonenzymatically glycated proteins under physiological conditions. Eur J Biochem 210: 729–739, 1992
Cohen MP, Hud E, Wu VY: Amelioration of diabetic nephropathy with monoclonal antibodies against glycated albumin. Kidney Int 45: 1673–1679, 1994
Gumkowski F, Kaminska G, Kaminski M, Morrissey LW, Auerbach R: Heterogeneity of mouse vascular endothelium. Blood Vessels 24: 11–23, 1987
Wolf G, Sharma L, Chen K, Ericksen M, Ziyadeh FN: High glucose-induced proliferation in mesangial cells is reversed by autocrine TGF-β. Kid Int 42: 647–656, 1992
Haneda M, Kikkawa R, Horide N, Togawa M, Koya D, Kajiwara N, Ooshima A, Shigeta Y: Glucose enhances Type IV collagen production in cultured rat glomerular mesangial cells. Diabetologia 34: 198–200, 1991
Ziyadeh FN, Snipes ER, Watanabe M, Alvarez RJ, Goldfarb S, Haverty TP: High glucose induces cell hypertrophy and stimulates collagen gene expression in proximal tubule. Am J Physiol 259: F704–714, 1990
Ziyadeh FN, Cohen MP: Effects of glycated albumin on mesangial cells: Evidence for a role in diabetic nephropathy. Molec and Cellular Biochemistry 125: 19–25, 1993
Brownlee M, Cerami A, Vlassara H: Advanced glycosylation end products and the biochemical basis of diabetic complications. New Engl J Med 318: 1315–1321, 1988
Esposito C, Gerlach H, Brent J, Stern D, Vlassara H: Endothelial receptor-mediated binding of glucose-modified albumin is associated with increased monolayer permeability and modulation of cell surface coagulant properties. J Exp Med 170: 1387–1407, 1989
Schmidt AM, Vianna M, Gerlach M, Brett J, Ryan J, Kao J et al.: Isolation and characterization of two binding proteins for advanced glycosylation end products from bovine lung which are present on the endothelial cell surface. J Biol Chem 267: 14987–14997, 1992
Silbiger S, Crowley S, Shan Z, Brownlee M, Satriano J, Schlondorff D: Nonenzymatic glycation of mesangial matrix and prolonged exposure of mesangial matrix to elevated glucose reduces collagen synthesis and proteoglycan charge. Kid Int 43: 853–864, 1993
Makita Z, Vlassara H, Cerami A, Bucala R: Immunochemical detection of advanced glycosylation end productsin vivo. J Biol Chem 267: 5133–5138, 1992
Crowley ST, Brownlee M, Edelstein D, Satriano JS, Mori T, Singhal PC, Schlondorff DO: Effects of nonenzymatic glycosylation of mesangial matrix on proliferation of mesangial cells. Diabetes 40: 540–547, 1991
Brujin JA, Roos A, de Geus B, de Heer E: Transforming growth factor β and the glomerular extracellular matrix in renal pathology. J Lab Clin Med 123: 34–47, 1994
Fausto N: Multifunctional roles for transforming growth factor-β1. Lab Invest 65: 497–499, 1991
Steffes MW, Bilous RW, Sutherland DER, Mauer SM: Cell and matrix components of the glomerular mesangium in Type I diabetes. Diabetes 41: 679–688, 1992
Kumazaki T, Kobayashi M, Mitsui Y: Enhanced expression of fibronectin duringin vivo cellular aging of human vascular endothelial cells and skin fibroblasts. Exper Cell Res 205: 396–402, 1993
Osterby R, Parving H-H, Hommel E, Jorgensen HE, Lokkegard H: Glomerular structure and function in diabetic nephropathy: Early to advanced stages. Diabetes 39: 1057–1063, 1990
Lorenzi M, Cagliero E: Pathobiology of endothelial and other vascular cells in diabetes mellitus. Diabetes 40: 653–659, 1991
Day JF, Ingelbretsen CG, Ingelbretsen WR, Baynes JW, Thorpe SR: Nonenzymatic glucosylation of serum proteins and hemoglobin: response to changes in blood glucose levels in diabetic rats. Diabetes 29: 524–527, 1980
Day JF, Thorpe SR, Baynes JM: Nonenzymatically glucosylated albumin:In vitro preparation and isolation from normal human serum J Biol Chem 254: 5955–5959, 1979
Guthrow CE, Morris MA, Day JF, Thorpe SR, Baynes J: Enhanced nonenzymatic glucosylation of serum albumin in diabetes mellitus. Proc Natl Acad Sci USA 76: 4258–4261, 1979
Winocur PH, Bhatnagar D, Kalsi P, Hillier VF, Anderson DC: Relative clinical usefulness of glycosylated serum albumin and fructosamine during short-term changes in glycemic control in IDDM. Diabetes Care 12: 665–672, 1989
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Cohen, M.P., Hud, E., Wu, VY. et al. Glycated albumin modified by amadori adducts modulates aortic endothelial cell biology. Mol Cell Biochem 143, 73–79 (1995). https://doi.org/10.1007/BF00925929
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00925929